Comprehensive Injections
NIMA’s Comprehensive Injections training course provides one-on-one training to refine skills in full-face assessment and treatment. Students will learn to evaluate the face, prescribe ideal treatment plans, and maintain a natural look while achieving full correction. The course covers key treatment areas including the upper, mid, and lower face, lips, and jawline, with theory on facial anatomy, product selection, proper dosing, and incident management.
Target Audience
This activity is intended to meet the needs of all physicians, physician associates, and nurses who are interested in performing basic cosmetic injections.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Identify and locate key anatomical structures as they apply to the safe and efficacious use of Neurotoxin (BoNTA), deoxycholic acid and dermal filler injections.
- Select the Neurotoxin (BoNTA), deoxycholic acid and/or filler product that provides the safest and most efficacious result for the targeted treatment site.
- Implement safe and efficacious injection procedures and be able to recognize and implement appropriate treatment protocol of any potential adverse events.
- Review evidence-based basic injection techniques as well as introduce evidence-based alternative injection techniques of routinely injected treatment sites to their practice.
- Apply evidence-based principles and techniques for optimal facial enhancement for injecting Neurotoxins (BoNTA), deoxycholic acid and dermal fillers to injection sites not previously injected.
- Recognize and implement appropriate treatment protocol of potential adverse events at treatment sites not previously injected.
- Utilize alternative injecting techniques and dosages of Neurotoxins (BoNTA), deoxycholic acid and/or dermal fillers beyond their current experience safely and efficaciously into previously injected treatment sites.
- Introduce safe and efficacious treatment of Neurotoxins (BoNTA), deoxycholic acid and/or dermal fillers to injection sites not previously treated.
- Recognize and implement appropriate treatment protocol of injected treatment sites.
Commercial Support
There is no commercial support for this activity.
All of the relevant financial relationships listed for these individuals have been mitigated.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and NIMA Institute. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 17.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
Available Credit
- 17.50 AAPA Category 1 CME
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 17.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. - 17.50 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 17.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 17.50 ANCC Contact Hours
Credit being awarded: 17.50 ANCC contact hours
- 17.50 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 17.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Price
Criteria for Success
To obtain credit, you must complete the activity evaluation and claim credit based on your attendance. The Certificate of Completion is immediately available for download after submitting your evaluation. It will remain in your profile transcript for future retrieval if needed. It can be found under My Account > My Activities > Completed Activities.
If you have any questions, contact [email protected].

Facebook
X
LinkedIn
Forward